| Margarethe M Chobanian, MD | |
|
437 South Main St, Bradford, VT 05033 | |
| (802) 222-9317 | |
| (802) 222-9276 |
| Full Name | Margarethe M Chobanian |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 437 South Main St, Bradford, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851407118 | NPI | - | NPPES |
| 1011799 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0420010975 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Margarethe M Chobanian, MD P.o. Box 338, Little Rivers Health Care, Inc., Bradford, VT 05033 Ph: (802) 222-4637 | Margarethe M Chobanian, MD 437 South Main St, Bradford, VT 05033 Ph: (802) 222-9317 |
News Archive
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces that the Company's commercialization partner, Meda AB, has launched Medivir's unique cold sore treatment Xerese in the United States.
According to a new study in the American Journal of Preventive Medicine, almost 75 percent of US adults do not comply with public health guidelines recommending two or more muscle-strengthening exercise sessions a week, with nearly 60 percent of the population doing no MSE at all.
It may be that IQ tests are not the only way to measure human intelligence. Scientists at The Queensland Institute of Medical Science (QIMR) have identified two regions of the human genome that appear to explain variation in IQ. Their work was published this week in the American Journal of Human Genetics and has drawn world-wide interest.
CTI BioPharma Corp. today announced findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR).
› Verified 7 days ago
Mark Steven Harris, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1123 South Rd, Bradford, VT 05033 Phone: 802-272-2674 | |
Dr. Rebecca Leigh Yukica, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 331 Upper Pln, Bradford, VT 05033 Phone: 802-222-4722 Fax: 802-222-4709 | |
Mr. Thomas Clark, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 331 Upper Plain, Bradford, VT 05033 Phone: 802-222-4722 Fax: 802-222-4709 |